Gycaemic control and treatment profile amongst 20646 adult type 2 diabetes mellitus: a descriptive report by Chew, Boon How et al.
Pertanika J. Sci. & Technol. 22 (1): 95 - 103 (2014)
SCIENCE & TECHNOLOGY
Journal homepage: http://www.pertanika.upm.edu.my/
ISSN: 0128-7680  © 2014 Universiti Putra Malaysia Press.
Gycaemic Control and Treatment Profile amongst 20646 Adult 
Type 2 Diabetes Mellitus: A Descriptive Report
Chew, B. H.1*, Lee, P. Y.1, Mastura, I.2, Cheong, A. T.1, Sri Wahyu, T.3 and  
Zaiton, A.1
1Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malysia, 
43400 Serdang, Selangor, Malaysia
2Klinik Kesihatan Seremban 2, Jalan S2 A2, Seremban 2, 70300 Seremban, Negeri Sembilan, Malaysia
3Klinik Kesihatan Simpang Kuala, 05400 Alor Setar, Kedah, Malaysia
ABSTRACT
An audit of Diabetes Control and Management-Diabetes Registry Malaysia (ADCM-DRM) was started 
to monitor the provision of diabetes care in the country. A total of 20,646 patients were registered in 
the registry until 31st December 2008. This report set out to determine the Type 2 diabetes controls and 
treatment profiles of these cohorts of patients. This was a registry-based observational study conducted 
from May to December, 2008. An online standard case record form was available for site data providers 
to register their diabetic patients aged 18 years old and above annually. Demographic data, diabetes 
duration, treatment modalities, as well as various risk factors and diabetes complications were reported. 
Data were analyzed using Data Analysis and Statistical Software (Stata) version 9. A total of 81 centres, 
6 of which were hospitals, participated in this registry until 31st December 2008, contributing a total 
of 20646 patients. A majority of them (99.2%) had Type 2 diabetes mellitus. The mean HbA1c was 
8.0% (SD 2.10), with 30.1% and 17.9% of the patients who attained HbA1c < 7% and HbA1c < 6.5%, 
respectively. Metformin was prescribed more than sulfonylurea while only 11% had insulin. A review of 
the diabetic care policy and strategies in the primary health care clinics is needed to implement a more 
effective treatment of diabetes in this country.
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INTRODUCTION
The number of people with diabetes is 
expected to increase alarmingly in the coming 
decades. In 1985, an estimated 30 million 
people worldwide had diabetes; in 2000, a 
little over a decade later, the figure had risen 
to over 150 million. By 2030, the figure is 
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expected to rise to 439 million (International Diabetes Federation, 2009). The prevalence of 
diabetes mellitus in Malaysian adults aged 30 years old and above has doubled over the ten 
year period from 8.3% in 1996 to 14.9% in 2006 (National Health Morbidity Survey,1996; 
Institute of Public Health, 2008). According to the International Diabetes Federation estimates 
for 2010 and 2030, Malaysia is among the top ten countries with the highest prevalence of 
diabetes mellitus (International Diabetes Federation, 2009).
Diabetes mellitus is one of the commonest chronic, non-communicable diseases which 
contribute to a high level of morbidity and mortality globally with its impacts coming not 
only from diabetes mellitus itself, but mainly arising from its complications such as coronary 
artery disease and chronic kidney disease (Garcia et al., 1974; National Health Morbidity 
Survey, 1996; Lim et al. 2009). Studies have shown that with good glycaemic control and 
control of other concomitant cardiovascular risk factors, there would be delay in complications 
(The Diabetes Control and Complications Trial Research Group, 1993; UKPDS, 1998; Berl 
et al., 2003; Sever et al., 2005; Patel et al., 2007; Action to Control Cardiovascular Risk in 
Diabetes Study Group, 2008; ADVANCE Collaborative Group, 2008). Findings from UKPDS 
showed that for every 1% reduction in HbA1c, there was 37% reduction in micro-vascular 
complications, about 40% reduction of all diabetic-related end-points, myocardial infarction 
and death in the metformin sub-group analysis (UKPDS, 1998). This protective effect of early 
intensive glycaemic control persisted into the following decade post study (Holman, 2008). 
However, the achievement of the control to the recommended target level is not satisfactory. 
Clinical audit is one of the measures which health care providers use to assess and monitor their 
care to the patients. By implementing changes to the shortfalls found, health care providers 
hope to improve on the quality of care to the patients and subsequently delay the complications. 
Clinical audit is one of the measures which health care providers may use to assess and 
monitor their care to the patients (Costa, 2009). An online diabetes registry database called the 
“Audit of Diabetes Control and Management-Diabetes Registry Malaysia (ADCM-DRM)” was 
started in July 2008 as a pilot project in Negeri Sembilan (NS) (ADCM manual; CRC, Kuala 
Lumpur). The objectives of this online registry was to gather and monitor the provision of 
diabetes care; hence, to better inform outcomes of treatment, budget planning, health education 
for both the physician and patients as well as to increase awareness of the potential serious 
impact of this disease on the country (Stamler et al., 1993; American Diabetes Association, 
1998; American Diabetes Association, 2001). This registry was managed by a secretariat based 
at Clinical Research Centre, Hospital Kuala Lumpur. The main source data providers (SDP) 
were those from government health clinics and hospitals throughout NS, Selangor and Perak. 
This report set out to determine the Type 2 diabetes controls and treatment profiles as up to 
31st December 2008.
MATERIALS AND METHODS
This study was approved by the Medical Research Ethics Committee (MREC), Ministry of 
Health, Malaysia. ADCM-DRM database from July to 31st December 2008 was cleaned before 
the analyses were carried out. All public hospitals and health clinics were invited to participate 
as SDP. Participation was voluntary. An online standard case record form (CRF) was available 
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in the ADCM website for SDP to register their diabetic patients aged 18 years old and above 
annually. This was done by trained physicians and paramedics. Patients with T2D were defined 
as when their case record fulfilled all these criteria: (1) either documented diagnosis of diabetes 
mellitus according to World Health Organisation (WHO) criteria, or (2) those whose current 
treatment consisted of life-style modification, on oral anti-diabetics or insulin. The data 
captured include demography, diabetes duration, treatment modalities, as well as various risk 
factors and diabetes complications. Each of the selected SDP site administrators was given a 
password guarded access to the website in order to generate local data that was analysed by 
the secretariat. Data were analysed using STATA version 9. The detailed methodology of this 
project has been described elsewhere (Mastura et al., 2008).
RESULTS
A total of 81 centres, 6 of which were hospitals, participated in this registry until 31st December 
2008, contributing a total of 20,646 patients. A majority of the patients (89.6%) were from 
Negeri Sembilan and most of the cases were Type 2 diabetes mellitus (T2D) (99.2%). In more 
specific, 57.2% were females, while Malays made up 57.1%, Chinese were 19.7%, Indians 
formed 22.6% and other races made up 0.2% (see Table 1). The mean age was 58.0 years (SD 
11.49) with 77.6% of them aged 50 years old and above. About 82% of the patients had their 
body mass index (BMI) in the overweight category (BMI ≥ 23 Kgm-2), with 42.3% of them who 
were actually at least in the Obese class I (BMI ≥ 27.5 Kgm-2). The mean age at diagnosis was 
54.8 years old (SD 11.47) and the mean duration of diabetes was 4.7 years (SD 4.20) (see Fig.1).
TABLE 1 
Demographic profile
Profile n (%)
Gender
Male 8687 (42.4)
Female 11722 (57.2)
Missing 72 (0.4)
Ethnicity
Malay 11694 (57.1)
Chinese 4026 (19.7)
Indian 4637 (22.6)
Other Malaysian 48 (0.2)
Non – Malaysian 7 (0.03)
Missing 69 (0.3)
Age group (years)
< 30 178 (0.9)
30-49 4423 (21.6)
50-69 12424 (60.7)
≤ 70 3456 (16.9)
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Fig.1: The percentage of patients according to duration of diabetes
The mean casual blood glucose (CBG) and fasting blood glucose (FBG) were 11.1 mmol/L 
(SD 4.47) and 8.4 mmol/L (SD 3.26), respectively. The mean HbA1c was 8.0% (SD 2.10) out 
of about two thirds of tests carried out (Table 2). From a total of 13310 HbA1c test results 
available for analysis, 4012 (30.1%) of the patients attained HbA1c < 7% and 2386 (17.9%) 
achieved HbA1c < 6.5%.
Table 3 shows the treatment modalities of the patients. There were 326 (1.6%) patients 
who were prescribed diet control only. Most of the patients (42.7%) were on two and more oral 
anti-diabetic agents (OAD) as compared to monotherapy of OAD (34.9%). The most common 
OAD was either Metformin (75.9%) or a sulfonylurea (60.8%). Insulin was prescribed in a 
total of 2254 (11.0%) patients with about two thirds of them were prescribed in combination 
with OAD agents (see Table 3). Amongst the patients on insulin therapy, intermediate acting 
insulin was the most commonly used insulin (53%), followed by pre-mixed insulin (38.9%) 
and the least used was long-acting insulin (0.01%).
TABLE 2 
Glycaemic monitoring and profiles from July-December 2008
Measurement n, (% of the total patients) Mean (SD)
Casual blood glucose (mmol/L) 11200 (54.7) 11.1 (4.47)
Fasting blood glucose (mmol/L) 14214 (69.4) 8.4 (3.26)
2 hrs Post-prandial (mmol/L) 5825 (28.4) 13.3 (4.58)
HbA1c (%) 13764 (67.2) 8.0 (2.10)
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TABLE 3 
Treatment Modalities
Treatment Modalities n (%)
Diet only 326 (1.6)
Oral anti-diabetic agent only
- Monotherapy (OAD) 7142 (34.9)
- ≥2 OAD 8753 (42.7)
OAD & Insulin 1415 (6.9)
Insulin only 839 (4.1)
DISCUSSION
There was a huge majority of T2D (99.2%) in the registry as it was expected from the mainly 
primary care set-ups of the site data providers. Hence, Type 1 diabetes mellitus patients were 
rarely seen at these health clinics, as few as an average of less than 2 patients per centre. Negeri 
Sembilan contributed the most number of patients because this project was initiated in this state 
from the beginning. The gender composition was typical of attendance to any of the Malaysian 
health care centres and services, whereby female attendance (57.2%) being more common than 
the male. However, the difference was not as large as usually seen, most probably owing to 
the fact that a large majority of patients were retired individuals (77.6% being older than 50 
years old). The ethnicity composition did not reflect the national representation as evidenced 
by the Indians (22.6%) being the second most common users of these health facilities instead 
of the Chinese (19.7%). This phenomenon is not unexpected since the Indians are the ethnic 
group mostly affected by diabetes and the Chinese could be getting their health care needs 
from the private health care sectors (National Health Morbidity Survey, 1996; Institute of 
Public Health, 2008). This registry confirmed the belief that most of the T2D patients seen at 
the primary care level were at the early stage of the disease as there were more than half who 
were diagnosed less than 5 years ago.
FBG was the most commonly carried out test for the patients and this was closely followed 
by HbA1c; about two thirds (67.2%) of the patients managed to have HbA1c tested in the 
past one year. This was comparable to another study in 19 public hospitals across Peninsular 
Malaysia which reported annual testing rates of 67.9% for HbA1c (Mafauzy, 2006). The 
mean HbA1c of 8.0% in this survey was better when compared to data of 8.6% from tertiary 
centres and hospitals (Ismail et al., 2000). However, the figure is higher than in another study 
conducted in a government primary health centre in East Malaysia, where the average HbA1c 
was 7.4% (Wong & Rahimah 2004). This survey found that 30.1% of the patients attained 
HbA1c < 7% and 17.9% achieved HbA1c < 6.5%. The control profile was rather similar to 
both the local and United States academic primary care centres (Eid et al., 2004; Chew et al., 
2011; McFarlane et al., 2002). Studies in public hospitals (Mafauzy, 2006) and another study 
in an urban primary health care centre (Wong & Rahimah, 2004) have shown better results. 
The reason for the difference could be due to the level of care. Patients from hospital and 
urban health clinics are mainly managed by specialist or senior medical officers whereas our 
survey included rural districts where the patients may be managed by medical assistants or 
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junior medical officers. Lack of awareness and adherence to clinical guidelines, heavy patient 
load and restricted access to “List A” drugs like premixed insulin and safer sulphonylurea, 
glicazide may be the other factors for poorer results in the public primary healthcare clinics 
in our survey (Tan et al., 2008).
We observed that a few patients were on diet control alone as their treatment. This was not 
surprising among the present study cohorts of patients in the early stage of diabetes mellitus 
who might be asymptomatic and had HbA1c < 6.5% or FBG < 6.0 mmol/L in accordance to 
the recommendation of the national clinical practice guidelines (Malaysian Clinical Practice 
Guidelines for the Management of Type 2 Diabetic Mellitus, 2009). This registry reported 
a positive finding that more metformin than sulfonylureas was prescribed now compared to 
earlier studies in the country (Sarojini et al., 2008) and Thailand (Kosachunhanun et al. 2006) 
that showed the reverse scenario. The first line of anti-diabetic with metformin was appropriate 
in this youngish cohort and contra-indication of metformin is rather rare in primary healthcare 
clinical practice. This similar observation was also noted in the United Kingdom general practice 
since 2002, when metformin use surpassed sulfonylureas (Filion et al., 2009). However, the 
insulin use, both alone and in combination with other OAD agents, was still very low (11%) and 
this may explain rather poor diabetic control rate amongst the T2D patients in the community. 
The National Health Morbidity Survey in 2006 showed only 7.2% insulin usage, both alone 
and in combination with oral anti-diabetics. Under-utilization of insulin is also found in other 
studies in primary care clinic and hospital (Wong & Rahimah, 2004; Tan et al., 2008). This 
could be due to the resistance to use insulin by the healthcare provider and the low acceptance 
of insulin therapy by patients due to misconception of insulin risk and interference of routine 
life-style (Nathan, 2002; Cefalu, 2002; Karter et al., 2010).
The limitations of this registry are the retrospective data retrieval from patients’ records 
by mainly non-treating parties leading to incompleteness and inaccuracy. As the registry was 
not compulsory, many health centres did not participate, leading to biased patient population 
from only the participating centres. Thus, the data presented here could not be generalized to 
the whole primary care in Malaysia as a major proportion of the patients were from Negeri 
Sembilan.
CONCLUSION
ADCM-DRM is gaining momentum since its inception as evidenced by the ever increasing 
number of site participation and patients registered into the registry. The control profile was 
rather fair and showed no improvement as compared to earlier glycaemic control profile in the 
country many years ago. There was under-utilization of insulin which could have caused poor 
glycaemic control in the majority and this insulin acceptance and adherence can be improved 
with better patient education and self-management training. A review of the diabetic care 
policy and strategies in the primary health care clinics is needed to implement a more effective 
treatment of diabetes.
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